Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Pharmacokinetics of enantiomers of oxiracetam in rats

Wu-San Wang1 , Yu-Feng Wen2

1Department of Pharmacology, College of Pharmacy; 2School of Laboratory Medicine, Wannan Medical College, Wuhu, Anhui Province 241002, China.

For correspondence:-  Wu-San Wang   Email: vq1277@163.com

Accepted: 27 November 2018        Published: 27 December 2018

Citation: Wang W, Wen Y. Pharmacokinetics of enantiomers of oxiracetam in rats. Trop J Pharm Res 2018; 17(12):2483-2487 doi: 10.4314/tjpr.v17i12.26

© 2018 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the differences in pharmacokinetics of S-oxiracetam (S-ORT) and R-oxiracetam (R-ORT) in rats.
Methods: Sprague-Dawley rats (20) were randomly divided into two groups (ten rats per group), viz, S-ORT and R-ORT groups. Rats in S-ORT group received 200 mg S-ORT/kg while rats in R-ORT group were given 200 mg R-ORT/kg. Both treatments were given orally, and blood samples were collected at fixed time intervals for analysis. Ultra performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UPLC–ESI-MS/MS) was used for pharmacokinetic analysis. Portions of the rat plasma were also subjected to configurational transformation analysis using normal phase-high performance liquid chromatographic (NP-HPLC) fitted with a Chiral OC column. Blank blood samples from five rats were used for plasma protein binding rate studying.
Results: The two enantiomers did not transform into each other after oral administration, and the concentrations of S-ORT at 1, 1.5 and 2 h were significantly higher than those of R-ORT (p < 0.05). The area under the curve (AUC0-∞) and maximum concentration (Cmax) of S-ORT were also significantly larger than those of R-ORT (p < 0.05). There were no stereoselective differences between the two enantiomers.
Conclusion: There are significant differences in absorption between two ORT enantiomers, and this may result in different pharmacological effects.

Keywords: S-oxiracetam, R-oxiracetam, Configuration, Pharmacokinetics, Rats

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates